Training in the Molecular Biology of Neurodegeneration

神经退行性变分子生物学培训

• 批准号: 6740817
• 负责人: Bruce A YANKNER
• 金额: $ 67.96万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 1992
• 资助国家: 美国
• 起止时间: 1992-09-30 至 2007-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6740817
• 关键词: Training; Molecular; Biology; Neurodegeneration

DESCRIPTION (provided by applicant): We propose to continue a highly successful inter-departmental and inter-institutional Training Program in the Molecular Biology of Neurodegeneration - a program devoted to the training of pre- and postdoctoral students for careers as independent research scientists in universities and health-related research laboratories. The trainers are all Harvard faculty with active research programs in Alzheimer's disease and other neurodegenerative disorders related to aging. They are drawn from the Harvard Medical School and five affiliated research hospitals: Beth Israel-Deaconess Hospital, Brigham and Women's Hospital, Children's Hospital, Massachusetts General Hospital, and McLean Hospital. Bringing a wide range of experience and experimental approaches to the problems of age-related neurodegeneration, the Program faculty include molecular biologists, geneticists, cell biologists, neuropathologists, and biochemists. The pre-doctoral students are recruited into and drawn from the graduate students in the degree-granting Neuroscience Program of the Harvard Medical School. The postdoctoral students are chosen from among applicants nominated by individual faculty members of the Program. A total of six pre-doctoral trainees and eight postdoctoral trainees is proposed for a primary training faculty of 31 individuals experienced in basic and applied studies of age-related neurodegeneration. In all cases, the main criteria for successful candidates is dedication and interest in aging and neurodegeneration research and the highest level of academic achievement in their previous training. All students are required to participate in special neurodegeneration courses and seminars. The purpose of the Program is to create a framework within which the best training of future researchers devoted to problems in aging and neurodegeneration can take place and the already extensive interactions among the Program faculty can be continued.

描述（由申请人提供）：我们建议继续高度重视 成功的跨部门和跨机构培训计划 神经退行性变的分子生物学 - 一个致力于培训 作为独立研究科学家的博士前和博士后学生 在大学和健康相关的研究实验室。培训师都是 哈佛大学教师在阿尔茨海默病和 其他与衰老相关的神经退行性疾病。它们是从 哈佛医学院和五家附属研究医院：贝丝 以色列女执事医院、布莱根妇女医院、儿童医院、 马萨诸塞州总医院和麦克莱恩医院。带来了广泛的 解决与年龄有关的问题的经验和实验方法 神经退行性疾病，该计划的教员包括分子生物学家， 遗传学家、细胞生物学家、神经病理学家和生物化学家。 博士前生从研究生中招收和抽调 哈佛医学院神经科学学位授予项目的学生 学校。博士后学生是从提名的申请人中选出的 由该计划的个别教职人员。博士预科共有6名 拟对实习生和八名博士后实习生进行初步培训 由 31 名具有基础和应用研究经验的教师组成 与年龄相关的神经退行性疾病。在所有情况下，成功的主要标准 候选人对衰老和神经退行性疾病研究有奉献精神和兴趣 以及他们之前培训中的最高学术成就。全部 学生必须参加特殊的神经退行性疾病课程，并且 研讨会。该计划的目的是创建一个框架，在该框架内 对致力于衰老和衰老问题的未来研究人员进行最好的培训 神经退行性变可能发生，并且之间已经广泛的相互作用 该计划的教师可以继续。